DEVELOPMENT OF VACCINES BASED ON ADENOVIRAL VECTORS: A REVIEW OF FOREIGN CLINICAL STUDIES (PART 2)

Currently, many human infectious diseases do not developed effective methods of treatment and prevention. One of the latest successes of biotechnology is the use of adenoviral vectors carrying immunodominant antigens  of various pathogens as genetically engineered vaccines  both  preventive and ther...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: L. V. Cherenova, T. V. Kashtigo, Kh. S. Saiadian, M. M. Shmarov
Médium: Artigo
Jazyk:Russo
Vydáno: SPb RAACI 2017-08-01
Edice:Medicinskaâ Immunologiâ
Témata:
adenoviral vector
vaccine
clinical trials
infectious diseases
human adenovirus
chimpanzee adenovirus
On-line přístup:https://www.mimmun.ru/mimmun/article/view/1307
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky